Peramivir API

Name	Peramivir
Chinese name	帕拉米韦
Cas Number	229614-55-5
Source	India
Qualifications	/-/-/-/-

Peramivir was developed by the American Bio-Crystal Pharmaceutical Co., Ltd. It is another new type of neuraminidase (NA) inhibitor anti-influenza after the successful development of zanamivir and oseltamivir and the listing in 1999 Viral drug is also the first neuraminidase inhibitor approved as a single intravenous injection. Peramivir is a cyclopentane anti-influenza virus drug, which can bind to the active site of influenza virus neuraminidase and has inhibitory activity against human influenza A and B viruses. Compared with oseltamivir, because peramivir is an injection with a long half-life, clinical use has the advantages of quick onset and long duration; on the other hand, peramivir and oseltamivir have different structures and are suitable for Treatment of patients resistant to oseltamivir. Laboratory tests have shown that peramivir can effectively fight against every known H5N1 virus, and it is extremely lethal, and it is not easy to make the virus resistant to drugs. It is a promising anti-flu drug. The terminal sales of Peramivir sodium chloride injection in China's public medical institutions exceeded 500 million yuan in 2019, with a compound growth rate of 195.34% in the past three years, and it is expected to exceed the 1 billion mark in 2020.

Hot Tags: peramivir api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Perindopril Tert butylamine Salt API, Edoxaban API, Pregabalin API, Temozolomide API, Brinzolamide API, Itraconazole Hydrochloride API

• Previous: Crotamiton/Universal API
• Next: Zaleplon API